Work

Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitors

Year: 2017

Type: article

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-017-4260-2

Authors: Kunal C. Kadakia, Kelley M. Kidwell, Nicholas J. Seewald, Claire F. Snyder, Anna Maria Storniolo, Julie L. Otte, David A. Flockhart, Daniel F. Hayes, Vered Stearns, N. Lynn Henry

Institutions: U-M Rogel Cancer Center, University of Michigan, Johns Hopkins University, Johns Hopkins Medicine, Indiana University School of Medicine, Indiana University Indianapolis, Sidney Kimmel Comprehensive Cancer Center, University of Utah, Huntsman Cancer Institute

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: American Cancer Society, Damon Runyon Cancer Research Foundation, Pfizer, National Institutes of Health, Novartis Pharma, National Cancer Institute, National Institute of General Medical Sciences, National Center for Research Resources

Awards: G1059851584, General Clinical Research Center, G3179426139, G466213475, G473988448, Research and Training for Behavioral Oncology Interventions, General Clinical Research Center, G9000014606, G9000139515, G9000152600, G9000175079, G9000231836, Indiana University Comprehensive Training in Clinical Pharmacology

OpenAlex ID: W2608008235

FWCI: 0.328

Cites: 24

Cited by: 12

Related to: 10